FdaApplication
ANDA 202626
Identifiers
- fda_app_no: ANDA202626
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN INSTITUTIONAL LLC |
| application_type | ANDA |
| approval_date | 2014-06-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION |
1 product